<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Nuclear Dynamics</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5B231E17-DE23-486D-B967-4B64E14A8718"><gtr:id>5B231E17-DE23-486D-B967-4B64E14A8718</gtr:id><gtr:firstName>Anne</gtr:firstName><gtr:surname>Corcoran</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FK010867%2F1"><gtr:id>BC46FD14-8E15-4348-B01A-1B79DC74F324</gtr:id><gtr:title>Adaptation of a high resolution, high throughput assay of immunoglobulin repertoires for commercial and clinical applications</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K010867/1</gtr:grantReference><gtr:abstractText>Our immune system makes millions of different antibodies to fight infection by cutting and pasting together large sets of antibody genes in many different combinations. It is currently not possible to measure them all and it would be extremely useful to be able to do so. First, immunodeficient patients who can't make antibodies could be diagnosed and treated quicker and more accurately. Second many companies are making mouse models that generate human antibodies as powerful therapies against specific infections. They need to know which antibodies are amplified in response to a particular infection. We have developed VDJ-seq, an assay that can identify several hundred thousand different mouse antibody sequences in a sample. We will adapt VDJ-seq to analyse immunodeficient human patient samples and mouse models producing human antibodies in a rapid, high-throughput, cost-effective way that aims to improve patient treatment and accelerate commercial discovery of therapeutic antibodies.</gtr:abstractText><gtr:fund><gtr:end>2013-12-04</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-09-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>138186</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Addenbrookes</gtr:description><gtr:id>0E1C8AC6-A5B3-4011-A2E1-F2FD2D35C676</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>5464cbb28af7c6.25851556-1</gtr:outcomeId><gtr:partnerContribution>Provision of patient samples, supporting data and clinical expertise</gtr:partnerContribution><gtr:piContribution>High-throughput analysis of patient antibody repertoires</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Primary School visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>01B21EEC-3DEA-4F24-990F-49E56F8DCE42</gtr:id><gtr:impact>Visits were made to a local school. 60 Year 4 to 6 primary school children attended presentations and hands-on practical related to our science.

The teachers reported an increase in understanding and interest in biological research and what real scientists do. We are frequently requested to visit.</gtr:impact><gtr:outcomeId>iE5zVoiNeU8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Babraham Institute Schools Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D7FE9555-75BC-4C72-89D4-854890B8A3BE</gtr:id><gtr:impact>12 GCSE and A level students spent a day in our lab, doing a small project. Many asked questions about our research and careers in biology.

The feedback afterwards from the students was that biological research was more interesting and scientists more normal than the students expected.</gtr:impact><gtr:outcomeId>WBvYPniQr9t</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>They have been used to better understand antibody repertoires in immunodeficient patients</gtr:description><gtr:firstYearOfImpact>2013</gtr:firstYearOfImpact><gtr:id>E8B4DBFE-28A4-43E3-A00E-E50F169C5C73</gtr:id><gtr:impactTypes/><gtr:outcomeId>5464c66d33b159.83358761</gtr:outcomeId><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have been able to examine in detail the antibody repertoires of immunodeficient patients who don't respond well to infections, and have found that they have a restricted repertoire compared to normal control subjects</gtr:description><gtr:exploitationPathways>They can be used to provide more accurate stratification of immunodeficient patients based on the diversity of their antibody repertoire and thus their potential to respond to infection.</gtr:exploitationPathways><gtr:id>042BF013-1609-47E7-9D4D-1C433CEDDAE5</gtr:id><gtr:outcomeId>5464c74cc31ab5.54947417</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>27AA3E1F-DF00-4C77-8480-2A99D87C7D43</gtr:id><gtr:title>Two Mutually Exclusive Local Chromatin States Drive Efficient V(D)J Recombination.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3ed529a13bc6244c700ab7464f36a75"><gtr:id>a3ed529a13bc6244c700ab7464f36a75</gtr:id><gtr:otherNames>Bolland DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58ca6fbc706546.50899776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE52C280-D63D-4BDB-A3EE-C1AF8327E2CC</gtr:id><gtr:title>Local Chromatin Features Including PU.1 and IKAROS Binding and H3K4 Methylation Shape the Repertoire of Immunoglobulin Kappa Genes Chosen for V(D)J Recombination.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc0870f7515e8b4f30848785a075bd90"><gtr:id>dc0870f7515e8b4f30848785a075bd90</gtr:id><gtr:otherNames>Matheson LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a8d5a57329573.11038574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>354B203C-DD9E-4AA1-B837-3A1EE2183463</gtr:id><gtr:title>Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/688e793756d75b71e00b59b28e505c81"><gtr:id>688e793756d75b71e00b59b28e505c81</gtr:id><gtr:otherNames>Ta VB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14946_26_23066158</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C33D0726-6C2E-43EA-8634-DB64AB1D6DE3</gtr:id><gtr:title>Local and global epigenetic regulation of V(D)J recombination.</gtr:title><gtr:parentPublicationTitle>Current topics in microbiology and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc0870f7515e8b4f30848785a075bd90"><gtr:id>dc0870f7515e8b4f30848785a075bd90</gtr:id><gtr:otherNames>Matheson LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-3-642-24102-4</gtr:isbn><gtr:issn>0070-217X</gtr:issn><gtr:outcomeId>doi_53cfcbfcb5c4d9a3</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K010867/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>